英文名稱 | Bemcentinib | R428 | BGB324 |
---|---|
中文名稱 | 貝森替尼 |
CAS號(hào) | 1037624-75-1 |
分子式 | C30H34N8 |
分子量 | 506.64 |
外觀 | Off-white to yellow powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | Bemcentinib | R428 | BGB324 |
---|---|
中文名稱 | 貝森替尼 |
CAS號(hào) | 1037624-75-1 |
分子式 | C30H34N8 |
分子量 | 506.64 |
外觀 | Off-white to yellow powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Bemcentinib (formerly known as BGB324; R428) is a novel, potent and selectiveinhibitor of the RTK (receptor tyrosine kinase) Axl with potential anticancer activity.
PMID: 21796150 DOI: 10.1038/jid.2011.218
PMID: 20145120 DOI: 10.1158/0008-5472.CAN-09-2997
PMID: 21285281 DOI: 10.1124/jpet.110.178046